Price Alert

Elevation Oncology Inc. (ELEV)

NASDAQ: ELEV · Real-Time Price · USD

0.38

0.06 (18.79%)

At close: Jun 09, 2025, 3:59 PM

Elevation Oncology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	60.49M	49.46M	48.2M	59.45M	90.63M	49.26M	54.88M	106.33M	55.9M	45.92M	52.59M	53.88M	53.01M	146.28M	155.2M	158.02M	69.91M
Short-Term Investments	20.16M	43.72M	54.87M	51.4M	13.42M	33.85M	39.92M	1.6M	18.03M	44.36M	55.27M	68.66M	79.05M	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	866K	940K	983K	1.02M	1.07M	1.11M	867K	975K	1.09M	1.31M	67K	25K	-6K	40K	65K	548K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	1.53M	1.54M	2.25M	2.72M	3.84M	4.86M	4M	1.5M	1.91M	2.7M	2.21M	1.14M	n/a	3.14M	3.24M	933K	n/a
Total Current Assets	82.19M	94.73M	105.32M	113.57M	107.89M	87.96M	98.8M	109.42M	75.83M	92.98M	110.07M	123.69M	134.25M	149.42M	158.44M	158.95M	71.11M
Property-Plant & Equipment	29K	34K	39K	45K	49K	59K	68K	78K	88K	98K	108K	30K	34K	38K	43K	47K	52K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	59.00	n/a	n/a	n/a	98.00	n/a	n/a	n/a	38K	n/a	n/a	52K
Total Long-Term Assets	29K	900K	979K	1.03M	1.07M	1.13M	1.18M	945K	1.06M	1.18M	1.42M	97K	59K	70K	83K	112K	652K
Total Assets	82.22M	95.63M	106.3M	114.6M	108.96M	89.09M	99.97M	110.37M	76.9M	94.16M	111.49M	123.78M	134.31M	149.49M	158.52M	159.06M	71.76M
Account Payables	492K	559K	2.63M	344K	435K	507K	3.64M	5.24M	4.04M	6.36M	5.67M	1.3M	882K	5.65M	5.43M	939K	672K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	3.74M	2.27M	1.59M	1.08M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	4.24M	4.47M	5.93M	2.76M	2.33M	4.14M	7.61M	8.42M	13.53M	15.69M	15.1M	19.09M	10.44M	8.79M	8.88M	3.71M	2.67M
Long-Term Debt	n/a	31.13M	31.02M	30.92M	30.81M	30.14M	29.95M	29.77M	29.6M	29.43M	29.27M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	31.25M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2K	3K	5K	7K	8K	10K	12K	97.2M
Total Long-Term Liabilities	31.25M	31.13M	31.02M	30.92M	30.81M	30.14M	29.95M	29.77M	29.6M	29.44M	29.27M	5K	7K	8K	10K	12K	97.2M
Total Liabilities	35.49M	35.6M	36.95M	33.68M	33.14M	34.28M	37.56M	38.19M	43.13M	45.13M	44.37M	19.1M	10.44M	8.8M	8.89M	3.73M	99.87M
Total Debt	n/a	31.13M	31.02M	30.92M	30.81M	30.14M	29.95M	29.77M	29.6M	29.43M	29.27M	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	6K	6K	6K	5K	5K	4K	4K	4K	2K	2K	2K	2K	2K	2K	2K	2K	n/a
Retained Earnings	-254.67M	-240.46M	-230.02M	-217.14M	-206.68M	-195.97M	-188.07M	-177.44M	-167.32M	-150.27M	-131.22M	-92.39M	-72.46M	-55.19M	-45.56M	-33.3M	-28.24M
Comprehensive Income	11K	61K	128K	-26K	-0.00	9K	-1K	-2K	-51K	-161K	-258K	-275K	-204K	-0.00	-158.52M	-159.06M	n/a
Shareholders Equity	46.73M	60.02M	69.36M	80.92M	75.82M	54.81M	62.42M	72.18M	33.76M	49.03M	67.12M	104.68M	123.87M	140.7M	149.63M	155.34M	-28.11M
Total Investments	n/a	43.72M	54.87M	51.4M	13.42M	33.85M	39.92M	1.6M	18.03M	44.36M	55.27M	68.66M	79.05M	n/a	n/a	n/a	n/a